Novartis’ Piqray combo becomes first Europe-approved therapy for PIK3CA-mutated advanced breast cancer
July 29, 2020Research and Development, Sales and Marketing Europe, Novartis, Piqray, breast cancer, pharma
The European Commission (EC) has awarded its approval for Novartis’ Piqray (alpelisib) to be made available in combination with fulvestrant …
UK Government secures 60 million doses of Sanofi and GSK’s COVID-19 vaccine
July 29, 2020Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK government, pharma
The UK Government has sealed another deal to procure an effective COVID-19 vaccine for its citizens, partnering up with Sanofi …
Roche’s Actemra fails to improve clinical status in COVID-19-associated pneumonia
July 29, 2020Research and Development Actemra, COVID-19, Roche, pharma
Roche has announced the disappointing news that its therapy Actemra/RoActemra (tocilizumab) failed to improve clinical status to a statistically significant …
Eli Lilly teams up with Chi-Med for Chinese sales of Elunate capsules
July 28, 2020Manufacturing and Production, Sales and Marketing Chi-Med, China, Eli Lilly
Eli Lilly Shanghai, an affiliate of the wider company, has enlisted the help of biopharma firm Hutchinson China MediTech, or …
Yale-backed study to test efficacy of AI-selected therapy in COVID-19
July 28, 2020Manufacturing and Production, Research and Development AI, COVID-19, clinical trial, pharma
Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …
Farxiga smashes all goals in Phase 3 chronic kidney disease trial, says AstraZeneca
July 28, 2020Manufacturing and Production, Research and Development AstraZeneca, farxiga
AstraZeneca has teased new data from a Phase 3 study of its sodium-glucose co-transporter-2 (SGLT2) inhibitor Farxiga (dapagliflozin) in the …
Kyowa Kirin’s Crysvita secures CHMP support in rare X-linked hypophosphataemia
July 28, 2020Manufacturing and Production, Sales and Marketing CHMP, EMA
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has given its backing to Kyowa Kirin’s …
Celltrion’s infliximab biosimilar Remsima secures European approval in five indications
July 27, 2020Manufacturing and Production, Sales and Marketing celltrion, infliximab, pharma, remsima
The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …
AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal
July 27, 2020Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma
AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …
US Government invests a further $472 million in Moderna’s BARDA-backed COVID-19 vaccine
July 27, 2020Research and Development, Sales and Marketing COVID-19, Moderna, US government, Vaccine
Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA) to support …
India’s National Task Force rejects Biocon’s itolizumab for COVID-19
July 27, 2020Sales and Marketing Biocon, COVID-19, India, Itolizumab
Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country …
Kite secures FDA approval for second CAR T therapy Tecartus in relapsed or refractory mantle cell lymphoma
July 27, 2020Sales and Marketing CAR T, CAR-T, FDA, Gilead, kite pharma
Kite Pharma has chalked up another regulatory success for its parent company Gilead with the news that the FDA has …
Two CHMP recommendations for AstraZeneca: Imfinzi in first-line lung cancer, Calquence in chronic lymphocytic leukaemia
July 27, 2020Sales and Marketing AstraZeneca, CHMP, Calquence, EMA, Imfinzi
AstraZeneca has secured two new recommendations for approval of its products from the European Medicines Agency’s Committee for Medicinal Products …
Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients
July 24, 2020Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark
The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …
Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis
July 24, 2020Medical Communications Eli Lilly, Humalog, diabetes, insulin
Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …
UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis
July 24, 2020Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis
UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …
Brazilian study finds hydroxychloroquine is not effective at treating COVID-19
July 24, 2020Medical Communications COVID-19, coronavirus, hydroxychloroquine, pandemic
Another study has shown hydroxychloroquine is ineffective in treating the coronavirus. The research was published in the New England Journal …
Top Ten most popular articles on Pharmafile.com this week
July 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories
As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals
July 23, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …
Biogen appoints Michael McDonnell as Chief Financial Officer and Executive Vice President
July 23, 2020Business Services
Biogen have announced that they have appointed Michael McDonnell as Executive Vice President and Chief Financial Officer, effective August 15, …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
